Wound Care Biologics Market Size, Business Revenue Forecast, Leading Competitors and Growth Trends 2027
Biologic wound care products involve assisting in wound
healing. Biologic wound care products restore the tissue integrity by
regeneration and scar formation. It is gaining popularity as a treatment
modality for the management of chronic wounds and burns injuries. Growing aging
population, increasing prevalence of chronic diseases and burn injuries, and
increasing healthcare expenditure are expected to drive the growth of the
market.
The global wound
care biologics market is anticipated to have held a value of USD 1.20
billion in the year 2017 and is expected to grow at a CAGR of 9.9% during the
forecast period. According to the American Diabetes Association, in 2015, about
30.3 million suffer from diabetes in the Americas. Moreover, in the US, 486,000
were suffering from burn injuries from 2011 to 2015. On other hand, the high
cost of treatment, lack of awareness, and poor education and training can
restrain the market growth over the assessment period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6563
Segmentation
The global wound care biologics market has been segmented
into product type, wound type, and end user.
Based on product type, the market is segmented into
biological skin substitutes and topical agents. The biological skin substitutes
segment is expected to account for the largest share and fastest growing
segment of the global market in 2017. The market growth of the segment is
attributed to increasing adoption and result oriented product.
Based on wound type, the market is segmented into ulcers,
surgical & traumatic wounds, and burns. The ulcer segment has been further
segmented into diabetic foot ulcer, pressure ulcer, venous leg ulcer, and
others ulcer.
The global wound care biologics market, by end user, has
been segmented into hospitals, clinics, and other end users.
Key Players
Some of the prominent players in the global wound care
biologics market are Integra LifeSciences Corporation (US), Smith & Nephew
(UK), Wright Medical (US), Mölnlycke Health Care AB (Sweden), MiMedx Group
(US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics
(US), Marine Polymer Technologies, Inc. (US), Kerecis (Iceland), Solsys Medical
(US), ACell (US), and Organogenesis (US).
Regional Analysis
Geographically, the Americas is expected to dominate the
global market owing to the presence of well-developed healthcare sector, rising
prevalence of diabetes, increasing rate of accidents and rising expenditure for
the healthcare sector. Europe is expected to hold the second largest position
in the global market owing to the growing prevalence of chronic diseases
coupled with increasing occurrences of burn cases. Asia-Pacific is expected to
be the fastest growing market owing to the large population base of the
diabetic patients and increasing developments in the healthcare segment.
Furthermore, the Middle East and Africa region is expected to account for the
least market share in the global market.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/wound-care-biologics-market-6563
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment